Adverse Effects of Low-dose Oral Minoxidil for Androgenetic Alopecia in 435 patients - Supplemental material
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Supplemental material.
补充材料。
应用场景：
创建时间：
2020-11-23
相关数据集
Figure S1 - Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
Annals of Pharmacotherapy published adverse drug reaction case reports assessed using the Liverpool ADR Causality Assessment Tool. (DOC)
NIAID Data Ecosystem100
Supplementary Material for: Exploring Mesenchymal Stem Cells versus Minoxidil for Androgenic Alopecia Treatment: A detailed Animal-Based Histological and Morphometric Study.
Introduction: Androgenic alopecia (AGA), a hair loss condition caused by Dihydrotestosterone (DHT) binding to hair follicle receptors, negatively impacts quality of life for both men and women. Curren
DataCite Commons2024-11-13 更新70
Supplementary Material for: Adverse Cutaneous Reactions to Monoclonal Antibodies: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Erythema Multiforme, and Fixed Drug Eruption – A Systematic Review
Background The therapeutic use of monoclonal antibodies (mAbs) has significantly increased since the first mAb was introduced. Despite their therapeutic benefits, mAbs have been accompanied by a rise
DataCite Commons2025-04-19 更新40
Human ADSC-Exo miRNA Sequencing
Androgenic alopecia (AGA) is the most common type of hair loss in dermatology, also known as male alopecia. The prevalence of male alopecia in China was 19.9% and increased with age, which seriously a
NIAID Data Ecosystem80
Microbiome in the hair follicle of androgenetic alopecia patients
Androgenetic alopecia is the most common form of hair loss in males. It is a multifactorial condition involving genetic predisposition and hormonal changes. The role of microflora during human hair lo
NIAID Data Ecosystem60
